These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16224517)

  • 1. [In vitro study of the antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer].
    Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY; Ye X; Zhu HL; Cheng HY; Cheng YX; Guo HF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):480-4. PubMed ID: 16224517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vivo study of antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer].
    Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY
    Ai Zheng; 2004 Jul; 23(7):777-81. PubMed ID: 15248911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effects of T cells induced by fusion protein 6B11-pulsed dendritic cells on ovarian carcinoma cells.
    Yang W; Feng J; Chang X; Fu T; Ye X; Zhang H; Li X; Wen H; Feng L; Tong C; Cui H
    Gynecol Oncol; 2007 Apr; 105(1):238-43. PubMed ID: 17383546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of immunization protocol of ovarian carcinoma associated 6B11 anti-idiotypical minibody].
    Zhu HL; Li Y; Chang XH; Cui H; Feng J; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):52-6. PubMed ID: 16635330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].
    Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Specific immune cell therapy against ovarian cancer in vivo and in vitro].
    Chang XH; Cheng HY; Cheng YX; Ye X; Guo HF; Fu TY; Zhang L; Zhang G; Cui H
    Ai Zheng; 2008 Dec; 27(12):1244-50. PubMed ID: 19079987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
    Chi PD; Li L; Fan YY; Wu CY
    Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immuno-therapeutic study of anti-idiotype minibody (single chain Fv-CH3) on ovarian carcinoma bearing mice].
    Li Y; Chang XH; Cui H; Yang WL; Feng J; Wei LH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):451-6. PubMed ID: 12974094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Induction of T cell responses against autologous ovarian cancer by anti-idiotype minibody-pulsed dendritic cells].
    Yang WL; Cui H; Feng J; Chang XH; Fu TY; Ye X; Zhang H; Li XP; Wen HW; Feng LM; Tong CR
    Ai Zheng; 2004 Dec; 23(12):1639-45. PubMed ID: 15601552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-tumor immune responses induced by a fusion protein of ovarian carcinoma anti-idiotypic antibody 6B11ScFv and murine GM-CSF in BALB/c mice.
    Cui H; Chang XH; Liu B; Feng J; Li Y; Ye X; Cao SJ; Fu TY; Yao Y; Li HQ; Qian HN
    Int J Gynecol Cancer; 2004; 14(2):234-41. PubMed ID: 15086722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation and characterization of monoclonal anti-anti-idiotypic antibody (3D12) of epithelial ovarian carcinoma].
    Zhang C; Cui H; Li Xp; Ye X; Fu Ty; Feng J; Chang Xh; Wei LH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):170-3. PubMed ID: 18458693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction, expression, and function of 6B11ScFv-mIL-12, a fusion protein that attacks human ovarian carcinoma.
    Cheng H; Ye X; Chang X; Ma R; Cong X; Niu Y; Zhang M; Liu K; Cui H; Sang J
    Med Oncol; 2015 Apr; 32(4):130. PubMed ID: 25794492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of humanized ovarian carcinoma anti-idiotypic minibody.
    Chang X; Cui H; Feng J; Li Y; Liu B; Cao S; Cheng Y; Qian H
    Hybrid Hybridomics; 2003 Apr; 22(2):109-15. PubMed ID: 12831536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of cellular immunity after intracavitary monoclonal antibody therapy of ovarian cancer.
    Kosmas C; Epenetos AA; Courtenay-Luck NS
    Cancer; 1994 Jun; 73(12):3000-10. PubMed ID: 8199996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-idiotypic monoclonal antibodies against anti-ovarian carcinoma monoclonal antibody COC166-9. Generation and application.
    Qian HN; Lu WY
    Chin Med J (Engl); 1994 Feb; 107(2):99-103. PubMed ID: 8194388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antigen mimicry of anti-idiotypic antibodies for human ovarian carcinoma antigen: generation and characterization of anti anti-idiotype antibodies].
    Lu WY; Qian HN
    Zhonghua Yi Xue Za Zhi; 1993 Oct; 73(10):581-3, 636. PubMed ID: 7508814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The induction of specific immunity to human ovarian carcinoma cells by anti-idiotypic antibodies].
    Lu WY; Qian HN; Li WJ
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jan; 29(1):27-9, 60-1. PubMed ID: 8033621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A robust immune system conditions the response to abagovomab (anti-idiotypic monoclonal antibody mimicking the CA125 protein) vaccination in ovarian cancer patients.
    Battaglia A; Fossati M; Buzzonetti A; Scambia G; Fattorossi A
    Immunol Lett; 2017 Nov; 191():35-39. PubMed ID: 28919454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of costimulatory molecule 4-1BB and CD28 in activating of various T cell subsets from human peripheral blood].
    Wu JY; Qian F; Lu HZ; Wang W; Li BQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):533-6. PubMed ID: 15367340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.